Clinical Trial: A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-A1 in Healthy Young Adults

U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07616934) titled 'A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-A1 in Healthy Young Adults' on May 18.

Brief Summary: This is a phase 1, first-in-human, randomized, double-blind, placebo-controlled, dose-escalation study to evaluate the safety, tolerability, and immunogenicity of VAX-A1 in healthy adults 18-40 years of age.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Group A Streptococcal Infection

Intervention: BIOLOGICAL: Placebo

0.5mL of placebo (normal saline) will be administered into the deltoid muscle

BIOLOGICAL: VAX-A1 Low

0.5mL of the low dose VAX-A1 will be administered into ...